ZA99393B - Trovafloxacin mesylate tablet. - Google Patents

Trovafloxacin mesylate tablet.

Info

Publication number
ZA99393B
ZA99393B ZA9900393A ZA99393A ZA99393B ZA 99393 B ZA99393 B ZA 99393B ZA 9900393 A ZA9900393 A ZA 9900393A ZA 99393 A ZA99393 A ZA 99393A ZA 99393 B ZA99393 B ZA 99393B
Authority
ZA
South Africa
Prior art keywords
trovafloxacin mesylate
mesylate tablet
tablet
trovafloxacin
mesylate
Prior art date
Application number
ZA9900393A
Other languages
English (en)
Inventor
Alton Dale Johnson
Christopher Michael Sinko
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA99393B publication Critical patent/ZA99393B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9900393A 1998-01-21 1999-01-20 Trovafloxacin mesylate tablet. ZA99393B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7201398P 1998-01-21 1998-01-21

Publications (1)

Publication Number Publication Date
ZA99393B true ZA99393B (en) 2000-07-21

Family

ID=22105016

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9900393A ZA99393B (en) 1998-01-21 1999-01-20 Trovafloxacin mesylate tablet.

Country Status (34)

Country Link
US (1) US6187341B1 (no)
EP (1) EP0930068A3 (no)
JP (1) JPH11269072A (no)
KR (1) KR100314977B1 (no)
CN (1) CN1227743A (no)
AP (1) AP1094A (no)
AR (1) AR012780A1 (no)
AU (1) AU758381B2 (no)
BG (1) BG103106A (no)
BR (1) BR9900116A (no)
CA (1) CA2259698C (no)
CO (1) CO4810225A1 (no)
DZ (1) DZ2712A1 (no)
EA (1) EA003247B1 (no)
GT (1) GT199900004A (no)
HR (1) HRP990023A2 (no)
HU (1) HUP9900154A3 (no)
ID (1) ID23735A (no)
IL (1) IL128051A0 (no)
IS (1) IS4947A (no)
MA (1) MA24747A1 (no)
NO (1) NO990243L (no)
NZ (1) NZ333838A (no)
OA (1) OA10958A (no)
PA (1) PA8466701A1 (no)
PE (1) PE20000169A1 (no)
PL (1) PL330981A1 (no)
SG (1) SG70666A1 (no)
SK (1) SK4299A3 (no)
TN (1) TNSN99007A1 (no)
TR (1) TR199900089A2 (no)
TW (1) TW518224B (no)
YU (1) YU2399A (no)
ZA (1) ZA99393B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142642A0 (en) * 1998-11-10 2002-03-10 Bayer Ag Pharmaceutical moxifloxacin preparation
CA2382834A1 (en) * 1999-09-20 2001-03-29 Alza Corporation Process for lessening polymorphic conversion of a drug
IL148820A0 (en) * 1999-10-08 2002-09-12 Smithkline Beecham Corp Fab i inhibitors
FR2808441B1 (fr) * 2000-05-04 2004-06-18 Oreal Utilisation de fibres dans une composition de soin ou de maquillage pour matifier la peau
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
WO2003088897A2 (en) * 2001-04-06 2003-10-30 Affinium Pharmaceuticals, Inc. Fab i inhibitors
EP1396263A1 (en) * 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
DK1575951T3 (da) * 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
CN100415284C (zh) * 2002-12-30 2008-09-03 毛友昌 六味木香片的制备方法
EP1608377B1 (en) 2003-03-17 2008-10-01 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
ES2297067T3 (es) * 2003-03-19 2008-05-01 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Composiciones farmaceuticas no higroscopicas que contienen acidos quinolinacarboxilicos de hidratados.
US8906413B2 (en) * 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
MXPA06000702A (es) * 2003-07-23 2006-04-11 Perrigo L Co Composicion que contiene fibra celulosica.
JP5087406B2 (ja) 2004-06-04 2012-12-05 アフィニウム ファーマシューティカルズ, インク. 治療薬ならびにその製造方法および使用方法
EP1809259B1 (en) * 2004-10-15 2014-12-03 Supernus Pharmaceuticals, Inc. Less abusable pharmaceutical preparations
JP2009518399A (ja) * 2005-12-05 2009-05-07 アフィニウム ファーマシューティカルズ, インク. Fabi阻害剤および抗菌剤としてのヘテロ環アクリルアミド化合物
WO2008009122A1 (en) 2006-07-20 2008-01-24 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab i inhibitors
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
DK2861608T3 (da) 2012-06-19 2019-06-24 Debiopharm Int Sa Prodrug-derivater af (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamid
CN108778286A (zh) 2016-02-26 2018-11-09 德彪药业国际股份公司 用于治疗糖尿病足感染的药物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US4957554A (en) 1989-08-16 1990-09-18 Minnesota Mining And Manufacturing Company Dimensionally-controlled ceramics
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
CA2229786C (en) * 1995-08-29 2002-02-19 David Bruning Joseph Zwitterionic forms of trovafloxacin

Also Published As

Publication number Publication date
EA003247B1 (ru) 2003-02-27
ID23735A (id) 2000-05-11
KR19990068014A (ko) 1999-08-25
PL330981A1 (en) 1999-08-02
IL128051A0 (en) 1999-11-30
CA2259698A1 (en) 1999-07-21
MA24747A1 (fr) 1999-10-01
HUP9900154A3 (en) 2000-12-28
EP0930068A3 (en) 1999-12-22
BG103106A (en) 1999-08-31
DZ2712A1 (fr) 2003-09-01
CO4810225A1 (es) 1999-06-30
AP1094A (en) 2002-08-19
PA8466701A1 (es) 2000-09-29
AU1217399A (en) 1999-08-12
AP9901443A0 (en) 1999-03-31
OA10958A (en) 2001-10-31
SK4299A3 (en) 2000-06-12
HUP9900154A2 (hu) 1999-09-28
US6187341B1 (en) 2001-02-13
SG70666A1 (en) 2000-02-22
YU2399A (sh) 2002-06-19
GT199900004A (es) 2000-07-08
TR199900089A3 (tr) 1999-10-21
NO990243D0 (no) 1999-01-20
TW518224B (en) 2003-01-21
NZ333838A (en) 2000-03-27
IS4947A (is) 1999-07-22
HU9900154D0 (en) 1999-03-29
TNSN99007A1 (fr) 2005-11-10
EA199900046A3 (ru) 1999-12-29
EP0930068A2 (en) 1999-07-21
KR100314977B1 (ko) 2001-11-24
PE20000169A1 (es) 2000-03-10
NO990243L (no) 1999-07-22
AU758381B2 (en) 2003-03-20
JPH11269072A (ja) 1999-10-05
HRP990023A2 (en) 1999-08-31
TR199900089A2 (xx) 1999-10-21
AR012780A1 (es) 2000-11-08
BR9900116A (pt) 2000-05-02
CN1227743A (zh) 1999-09-08
CA2259698C (en) 2003-04-15
EA199900046A2 (ru) 1999-08-26

Similar Documents

Publication Publication Date Title
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
PL355109A1 (en) Tert.
ZA200200477B (en) 2-pyrazolin-5-ones.
ZA99393B (en) Trovafloxacin mesylate tablet.
ZA996185B (en) Sulfanylsilanes.
ZA200005136B (en) Dihydropyrimides.
HK1054384A1 (en) 4-Pyrimidinyl-n-acyl-l-phenylalanines.
ZA200202537B (en) Pour-on-formulations.
HK1025144A1 (en) Hinge device.
HK1051199A1 (en) New phenylpiperazines.
ZA200203762B (en) 4-pyridinyl-IN-acyl-L-phenylalanines.
HK1029502A1 (en) Slider-pull-assembling unit.
HK1034298A1 (en) Scaffolding.
ZA992443B (en) Hydroxy-methyl-hexanones.
AU141186S (en) Tablet
ZA995325B (en) Methylcyclotetradec-5-en-1-ones.
ZA993123B (en) Trisresorcinyltriazines.
HK1036280A1 (en) Antivirals.
ZA200110454B (en) Pharmaceutical complex.
ZA200204581B (en) Nitro-sulfobenzamides.
HK1031254A1 (en) Tachogragh.
ZA992904B (en) Parbaked bread.
ZA200004838B (en) Electromembrane.
ZA200007026B (en) Acart.
ZA200203458B (en) Diaryl-enynes.